Project Grant R43DK143847
Award Date 9/15/25
Completion Date 8/31/26
Dollars Obligated $305K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- This Project Grant award of $278,224 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research program) supports the development of a novel, noninvasive "Burst Wave Lithotripsy" (BWL) technology to fragment larger kidney stones. The goal is to expand on prior successful testing of BWL for 10 mm stones to address the 10-20 mm stone range, while addressing key technical challenges around...
- This federal Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $306,867 award to Dupage Medical Technology Inc. supports the development of a new drug to treat ischemia-reperfusion injury associated with kidney transplantation. The project aims to develop a therapy that can reduce inflammation and thrombosis without causing excessive...
- This federal Project Grant award of $984,000.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The objective of this study is to test a novel treatment, sodium glucose co-transporter-2 inhibitor medications, for prevention of recurrent idiopathic calcium phosphate kidney stones. This research aims to develop new prevention strategies to lower the high...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $437,010 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of North Carolina at Chapel Hill. The grant, titled "Leveraging 'Smart Stent' Platform Technologies for AVF Maturation and More", aims to develop and test a biodegradable magnesium "smart stent" technology to improve early blood flow and minimize stenosis...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health, awarded a $350,000 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Microvascular Tissues, Inc. The grant supports the evaluation of a microvascular tissue graft treatment in rat models of diabetic peripheral neuropathy. The project aims to assess the ability of this novel microvascular tissue graft to improve...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), through its Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded a $350,000 Project Grant to Katharos, Inc. on Jun 20, 2025. The grant supports the development of a novel extracorporeal technology, the "Phosfilter" device, which aims to enhance phosphate removal from the blood of hemodialysis patients and reduce the incidence of high phosphate-associated morbidity and...
- This $128,286 Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research into the mechanisms of renal lipotoxicity and its contribution to the development of chronic kidney disease (CKD). The principal investigator will investigate the protective role of the FAF2 gene knockout in mitigating palmitate-induced lipotoxicity in...
- This federal Project Grant award of $684,107, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to assess the optimal settings of the Thulium Fiber Laser (TFL) for laser lithotripsy and associated thermal injury risk. The primary objectives are to: 1) determine the optimal TFL settings through in-vitro studies, 2) elucidate the mechanisms of action for TFL via...
- This federal Project Grant award of $155,011 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is supporting research to develop a deep learning model combining magnetic resonance (MAG3) renal scans and kidney ultrasound imaging data to more accurately diagnose unilateral ureteropelvic junction obstruction (UPJO) in children with antenatal hydronephrosis. The research...
- This federal Project Grant award in the amount of $1,695,959.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The funding supports research to evaluate the use of gadolinium-free kidney functional magnetic resonance imaging (MRI) as a non-invasive method to identify high-risk phenotypes in patients with chronic kidney disease (CKD). The key products and...